Executive record
Troy E. Wilson, Ph.D., J.D.
Most recent record: Kura Oncology, Inc. CFO transition: Jennifer Fulk to succeed Troy E. Wilson, Ph.D., J.D. (named as the outgoing officer), effective September 8, 2026.
1 verified record · 1 company
Career line from the records
1Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-09-08TransitionKura Oncology, Inc.
Kura Oncology, Inc. CFO transition: Jennifer Fulk to succeed Troy E. Wilson, Ph.D., J.D.Named as the outgoing officer
effective September 8, 2026 · 8-K filed September 8, 2026 · sec.gov, Item 5.02
Companies
1This page lists only verified filing records that name Troy E. Wilson, Ph.D., J.D., matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.